Pharmacological EZH2 inhibition combined with retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cells

BACKGROUND: Rhabdomyosarcomas (RMS) are predominantly paediatric sarcomas thought to originate from muscle precursor cells due to impaired myogenic differentiation. Despite intensive treatment, 5-year survival for patients with advanced disease remains low (< 30%), highlighting a need for novel t...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Brien, Eleanor, Tse, Carmen, Tracy, Ian, Reddin, Ian, Selfe, Joanna, Gibson, Jane, Tapper, William, Pengelly, Reuben J., Gao, Jinhui, Aladowicz, Ewa, Petts, Gemma, Thway, Khin, Popov, Sergey, Kelsey, Anna, Underwood, Timothy J., Shipley, Janet, Walters, Zoë S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588044/
https://www.ncbi.nlm.nih.gov/pubmed/37858275
http://dx.doi.org/10.1186/s13148-023-01583-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10588044/
https://www.ncbi.nlm.nih.gov/pubmed/37858275
http://dx.doi.org/10.1186/s13148-023-01583-w

Ejemplares similares